Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil P Johnson

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Lancet (London, England)|June 19, 2022
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)Linda C Giudice, Sawsan As-Sanie, Juan C Arjona Ferreira, et al.
BMC Medical Research Methodology|March 31, 2009
Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicineKimiko A Broeze, Brent C Opmeer, Lucas M Bachmann, et al.
The New England Journal of Medicine|May 20, 2017
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH AntagonistHugh S Taylor, Linda C Giudice, Bruce A Lessey, et al.
Human Reproduction Update|October 25, 2019
First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysisRui Wang, Wentao Li, Esmée M Bordewijk, et al.
Obstetrics and Gynecology|June 12, 2018
Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension StudiesEric Surrey, Hugh S Taylor, Linda Giudice, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Lancet (London, England)|June 19, 2022
Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)Linda C Giudice, Sawsan As-Sanie, Juan C Arjona Ferreira, et al.
BMC Medical Research Methodology|March 31, 2009
Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicineKimiko A Broeze, Brent C Opmeer, Lucas M Bachmann, et al.
The New England Journal of Medicine|May 20, 2017
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH AntagonistHugh S Taylor, Linda C Giudice, Bruce A Lessey, et al.
Human Reproduction Update|October 25, 2019
First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysisRui Wang, Wentao Li, Esmée M Bordewijk, et al.
Obstetrics and Gynecology|June 12, 2018
Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension StudiesEric Surrey, Hugh S Taylor, Linda Giudice, et al.
Pageof 8